B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

RXFP1

MOLECULAR TARGET

relaxin family peptide receptor 1

UniProt: Q9HBX9NCBI Gene: 5935018 compounds

RXFP1 (relaxin family peptide receptor 1) is targeted by 18 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting RXFP1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
12-Chloroadenosine 2-Chloroadenosine.1.102
2Methylene Blue0.691
3Aprepitant0.691
4Beclomethasone0.691
5Chlormadinone Acetate0.691
6Clotrimazole0.691
7Ethidium0.691
8Flunarizine Flunarizine is0.691
9Halcinonide0.691
10Hexachlorophene0.691
11oxatomide [Supplementary Concept] structure;0.691
12Oxymetholone0.691
13Oxyphenbutazone0.691
14rafoxanide0.691
15Rimonabant0.691
16Testosterone Propionate0.691
17Troglitazone0.691
18urolithin b0.691

About RXFP1 as a Drug Target

RXFP1 (relaxin family peptide receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 18 compounds with documented RXFP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

RXFP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.